Production (Stage)
Lixte Biotechnology Holdings, Inc.
LIXT
$1.33
-$0.0502-3.64%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 33.27% | -36.55% | -36.90% | -23.99% | -18.77% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 21.48% | 107.80% | -29.14% | -25.28% | 257.56% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 0.00% |
| Total Current Assets | 32.19% | -32.18% | -36.68% | -25.68% | -16.70% |
|
|
|||||
| Total Current Assets | 32.19% | -32.18% | -36.68% | -25.68% | -16.70% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 32.19% | -32.45% | -36.43% | -25.68% | -16.70% |
|
|
|||||
| Total Accounts Payable | 101.97% | -23.59% | -44.52% | -36.80% | 72.53% |
| Total Accrued Expenses | -- | -- | -- | -- | 6.89% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 3.19% | -8.20% | -11.72% | 34.24% | 37.56% |
| Total Other Current Liabilities | 3.19% | -8.20% | -11.72% | 34.24% | 37.56% |
| Total Current Liabilities | 11.56% | -3.25% | -21.95% | -8.92% | 47.44% |
|
|
|||||
| Total Current Liabilities | 11.56% | -3.25% | -21.95% | -8.92% | 47.44% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 11.56% | -3.25% | -21.95% | -8.92% | 47.44% |
|
|
|||||
| Common Stock & APIC | 2.11% | 0.16% | 0.22% | 0.27% | 0.21% |
| Retained Earnings | -1.36% | -1.20% | -1.95% | -2.04% | -2.00% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 12.42% | -25.30% | -70.12% | -235.63% | -175.51% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | 12.42% | -25.30% | -70.12% | -235.63% | -175.51% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 40.12% | -39.48% | -39.14% | -28.16% | -21.74% |
|
|
|||||